Leaders from Microsoft, Metro Bank, Boyd Gaming, Simplyhealth, and more join
PolyAI’s flagship conference to explore how AI fluency is transforming global industries
NEW YORK, Oct. 14, 2025 /PRNewswire/ — PolyAI today announced the full agenda and speaker lineup for VOX 2025, its annual flagship conference exploring the future of AI in customer experience. The virtual event takes place October 23, 2025 at 11:30 AM ET and is free to attend.
Centered on the theme “Fluent,” VOX 2025 brings together global leaders in technology, finance, healthcare, hospitality, and more who are redefining how enterprises connect to customers. The conference spotlights breakthroughs they’ve made leveraging AI and automation for real business results, including lifelike customer conversations, intelligent analysis, and measurable growth.
VOX 2025’s roster features:
Attendees of VOX 2025 can also expect an exclusive first look at PolyAI’s newest innovations — including multimodal capabilities and a tour of its Agent Studio platform — along with interactive breakout sessions for networking and sharing best practices.
“What makes VOX special is the caliber and diversity of voices we bring together each year,” said Mrkšić. “This year, we’re showcasing practitioners on the front lines of customer experience who’ve proven that fluency in AI leads to better conversations, smarter operations, and lasting customer trust.”
VOX 2025 is free to attend, open to everyone, and fully virtual. Click here to reserve your seat.
About PolyAI
PolyAI builds the world’s most lifelike AI agents for customer engagement — designed to handle complex conversations, deliver measurable results, and scale across industries. Our Agent Studio, the only voice-first omnichannel platform built on billions of data points from real customer interactions, helps enterprises like FedEx, Marriott, and Unicredit hold millions of conversations every year. Our clients achieve outcomes including 391% ROI and 83% faster call routing, and we’ve raised $120m to date from investors including NVIDIA and Khosla Ventures.
SOURCE PolyAI
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
This groundbreaking discovery has revealed a systemic metabolic dysfunction that creates a toxic exosome cargo…
Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…
Label-verified GaraHerb ingredient disclosures, manufacturing and policy transparency details, and what consumers searching for GaraHerb…
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES…
An informational overview examining category context, publicly available product disclosures, and what consumers often consider…